Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Mika Kuwahara"'
Autor:
Hiroaki Soyama, Morikazu Miyamoto, Hiroki Ishibashi, Masaya Nakatsuka, Haruka Kawauchi, Takahiro Sakamoto, Hiroko Matuura, Mika Kuwahara, Kazuki Takasaki, Hideki Iwahashi, Kento Kato, Masashi Yoshida, Masashi Takano, Hidenori Sasa, Kenichi Furuya
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 58, Iss 1, Pp 159-163 (2019)
Objective: Recently, Bakri balloon (BBT) was effective for women with placenta previa to reduce hemorrhage. However, about 10% of women needed to receive an invasive strategy. Thus, the identification of risk factors and the development of additional
Externí odkaz:
https://doaj.org/article/5aecbae27d9f4410b009704fbf2e5141
Autor:
Masashi Yoshida, Hiroki Ishibashi, Morikazu Miyamoto, Masaya Nakatsuka, Hidenori Sasa, Kenichi Furuya, Hiroaki Soyama, Masashi Takano, Hideki Iwahashi, Kazuki Takasaki, Hiroko Matuura, Mika Kuwahara, Haruka Kawauchi, Takahiro Sakamoto, Kento Kato
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 58, Iss 1, Pp 159-163 (2019)
Objective: Recently, Bakri balloon (BBT) was effective for women with placenta previa to reduce hemorrhage. However, about 10% of women needed to receive an invasive strategy. Thus, the identification of risk factors and the development of additional
Autor:
Hideki Iwahashi, Masashi Takano, Takahiro Sakamoto, Hiroko Matsuura, Tomoyuki Yoshikawa, Kenichi Furuya, Mika Kuwahara, Morikazu Miyamoto, Hiroaki Soyama, Kento Kato, Hiroki Ishibashi, Tadashi Aoyama, Kazuki Takasaki
Publikováno v:
Cancer Chemotherapy and Pharmacology. 81:809-814
To compare a cohort of patients with platinum-resistant recurrent ovarian cancer (PROC) treated with bevacizumab and gemcitabine (Bev–Gem) to that of patients treated only with gemcitabine (Gem). Between 2011 and 2017, we identified the Bev–Gem a
Autor:
Hiroko Matuura, Hiroki Ishibashi, Tadashi Aoyama, Kento Kato, Morikazu Miyamoto, Mika Kuwahara, Takahiro Sakamoto, Kenichi Furuya, Hideki Iwahashi, Tomoyuki Yoshikawa, Masashi Takano, Hiroaki Soyama, Hitoshi Tsuda
Publikováno v:
In Vivo. 32
Background/aim The purpose of this study was to compare the clinical behavior of several grades of endometrioid carcinoma (EC) compared to high-grade serous carcinoma (HGSC), based on World Health Organization 2014 criteria. Materials and methods Cli
Autor:
Hiroki Ishibashi, Tadashi Aoyama, Mika Kuwahara, Hiroko Matuura, Hideki Iwahashi, Kazuki Takasaki, Kenichi Furuya, Kento Kato, Morikazu Miyamoto, Takahiro Sakamoto, Hiroaki Soyama, Masashi Takano, Tomoyuki Yoshikawa
Publikováno v:
Anticancer Research. 38
Background/aim To investigate whether XIAP down-regulation and autophagy inhibition sensitize ovarian clear cell cancer cells to cisplatin. Materials and methods The ovarian clear cancer cell line KK was used for in vitro analysis. Hydroxychloroquine
Autor:
Mika Kuwahara
Publikováno v:
Journal of Japan Academy of Critical Care Nursing. 11:57-65
Autor:
Masashi Takano, Hideki Iwahashi, Mika Kuwahara, Kento Kato, Hiroki Ishibashi, Morikazu Miyamoto, Hitoshi Tsuda, Hiroko Matuura, Tadashi Aoyama, Tomoyuki Yoshikawa, Hiroaki Soyama, Takahiro Sakamoto, Kazuki Takasaki, Kenichi Furuya
Publikováno v:
Anticancer research. 38(2)
Aim To determine whether CD44, which is associated with tumor growth and metastasis, is related to carcinogenesis and prognosis in ovarian mucinous carcinomas (MACs). Materials and methods Tissue blocks from 71 patients with benign mucinous ovarian t
Autor:
Takahiro Sakamoto, Tomoyuki Yoshikawa, Hitoshi Tsuda, Hiroaki Soyama, Masashi Takano, Kenichi Furuya, Mika Kuwahara, Kazuki Takasaki, Tadashi Aoyama, Kento Kato, Hideki Iwahashi, Morikazu Miyamoto, Hiroko Matsuura
Publikováno v:
Medical oncology (Northwood, London, England). 34(12)
High-temperature-required protein A2 (HtrA2) is one of the serine proteases related to apoptosis. HtrA2 protein expression has been associated with cisplatin resistance and poor prognosis in ovarian serous adenocarcinoma (SAC). The aim of this study
Autor:
Morikazu Miyamoto, Kento Kato, Takahiro Sakamoto, Tomoyuki Yoshikawa, Mika Kuwahara, Masashi Takano, Kenichi Furuya, Hiroaki Soyama, Hiroko Matuura, Tadashi Aoyama, Kazuki Takasaki
Publikováno v:
Cancer chemotherapy and pharmacology. 81(1)
We aimed to retrospectively evaluate the efficacy and toxicity of an irinotecan hydrochloride (CPT) and nedaplatin (N) combination therapy for recurrent and refractory endometrial carcinoma, administered based on UGT1A1 genotype. Between 2009 and 201
Autor:
Shigeru Oono, Ken Shoji, Masayuki Oguro, Hitoshi Fukao, Akihiro Tamura, Mika Kuwahara, Hinako Kage
Publikováno v:
Journal of Environmental Engineering (Transactions of AIJ). 77:729-735